FDA acts to bolster supply of critically needed cancer drugs
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
European Medicines Agency and United States Food and Drug Administration to share manufacturing site inspections
- Details
- Category: EMA
![The European Medicines Agency The European Medicines Agency](/images/stories/logo/ema.gif)
FDA approves first generic version of cholesterol-lowering drug Lipitor
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
Drug not Shown to be Safe and Effective in Breast Cancer Patients
- Details
- Category: FDA
![The U.S. Food and Drug Administration The U.S. Food and Drug Administration](/images/stories/logo/fda.gif)
European Medicines Agency starts new review of cardiovascular risks of non-selective NSAIDs
- Details
- Category: EMA
![The European Medicines Agency The European Medicines Agency](/images/stories/logo/ema.gif)
European Medicines Agency reviews further data on narcolepsy and possible association with Pandemrix
- Details
- Category: EMA
![The European Medicines Agency The European Medicines Agency](/images/stories/logo/ema.gif)
European Medicines Agency completes its review of Avastin used in breast cancer
- Details
- Category: EMA
![The European Medicines Agency The European Medicines Agency](/images/stories/logo/ema.gif)
More Pharma News ...
- FDA begins process to remove breast cancer indication from Avastin label
- European Medicines Agency and ENCePP launch electronic Register of Studies
- FDA warns consumers not to use Vigor-25
- FDA: Include warnings on risk for class of prostate cancer drugs
- FDA: Possible increased risk of thigh bone fracture with bisphosphonates
- FDA issues final rule on safety information during clinical trials
- European Medicines Agency and U.S. Food and Drug Administration extend confidentiality arrangements